Patients with clinical conditions such as surgery, trauma, and acute medical illness have a
transiently increased risk of venous thromboembolism and merit consideration for adequate …

We have made great strides in the diagnosis, treatment and prevention of venous
thromboembolism (VTE). Despite these advances, however, questions remain. Perhaps the …

Perioperative prophylaxis of venous thromboembolism (VTE) usually coincides with the
duration of hospital stay, typically lasting between 5 and 14 days. However, mounting …

Low-molecular-weight heparins (LMWHs) are used widely in the treatment and prevention of
venous thromboembolism (VTE). The LMWHs dalteparin and enoxaparin reduce the rate of …

Objective: To review the published clinical data on prophylaxis for thromboembolism in
order to develop general guidelines to encourage the establishment of local protocols for …

Venous thromboembolism is the most common cause of preventable death among
hospitalised patients. Systematic prophylaxis with antithrombotic agents in patients at risk for …

Venous thromboembolism (VTE) is a serious complication during and after hospitalization,
yet is a preventable cause of in-hospital death. Without VTE prophylaxis, the overall VTE …

Venous thromboembolism is an important complication in patients undergoing major
orthopedic surgery. Without prophylaxis, there is a 50% to 60% incidence of deep vein …

Although pharmacologic prophylaxis against venous thromboembolism has become the
standard of care following total hip and knee replacement, prophylaxis among patients …

Prophylaxis for venous thromboembolism (VTE) after surgery has traditionally been given
from the time of surgery until hospital discharge, typically ranging from 5-14 days. Recently …